Sequential administration of XELOX and XELIRI is effective, feasible and well tolerated by patients with metastatic colorectal cancer.

Fukui, Taro; Suzuki, Koichi; Ichida, Kosuke; Takayama, Yuji; Kakizawa, Nao; Muto, Yuta; Hasegawa, Fumi; Watanabe, Fumiaki; Kikugawa, Rina; Saito, Masaaki; Tsujinaka, Shingo; Miyakura, Yasuyuki; Rikiyama, Toshiki

Fukui, Taro; Suzuki, Koichi; Ichida, Kosuke; Takayama, Yuji; Kakizawa, Nao; Muto, Yuta; Hasegawa, Fumi; Watanabe, Fumiaki; Kikugawa, Rina; Saito, Masaaki; Tsujinaka, Shingo; Miyakura, Yasuyuki; Rikiyama, Toshiki.

Afiliação

Fukui T; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Suzuki K; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Ichida K; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Takayama Y; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Kakizawa N; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Muto Y; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Hasegawa F; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Watanabe F; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Kikugawa R; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Saito M; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Tsujinaka S; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Miyakura Y; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.
Rikiyama T; Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Saitama 330-8503, Japan.

Oncol Lett ; 13(6): 4947-4952, 2017 Jun.

Article em En | MEDLINE | ID: mdl-28599498

Palavras-chave

XELIRI; XELOX; bevacizumab; metastatic colorectal cancer; sequential administration

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Oncol Lett Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão